WO2007144977A1 - Appareil pour mesurer la lumière biologique - Google Patents

Appareil pour mesurer la lumière biologique Download PDF

Info

Publication number
WO2007144977A1
WO2007144977A1 PCT/JP2006/325814 JP2006325814W WO2007144977A1 WO 2007144977 A1 WO2007144977 A1 WO 2007144977A1 JP 2006325814 W JP2006325814 W JP 2006325814W WO 2007144977 A1 WO2007144977 A1 WO 2007144977A1
Authority
WO
WIPO (PCT)
Prior art keywords
biological light
classification model
disease
waveform
subject
Prior art date
Application number
PCT/JP2006/325814
Other languages
English (en)
Japanese (ja)
Inventor
Naoki Tanaka
Masashi Kiguchi
Atsushi Maki
Shingo Kawasaki
Noriyoshi Ichikawa
Fumio Kawaguchi
Original Assignee
Hitachi Medical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Medical Corporation filed Critical Hitachi Medical Corporation
Priority to JP2008521091A priority Critical patent/JPWO2007144977A1/ja
Publication of WO2007144977A1 publication Critical patent/WO2007144977A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence

Definitions

  • the present invention relates to a biological optical measurement device that supports disease diagnosis non-invasively.
  • a biological light measurement device is a device that irradiates a living body with near-infrared light and measures light that has passed through the living body or reflected within the living body, and has blood circulation, hemodynamics, and hemoglobin content inside the living body. Since changes can be easily measured with low restraint and no harm to the subject, clinical application is expected.
  • Non-patent documents 1 and 2 below report that abnormalities occur in the pattern of hemoglobin changes in the frontal lobe by biophotometry in patients with mental illness such as depression and schizophrenia (schizophrenia). . Specifically, it has been reported that the integration values during the trial of the hemoglobin time waveform have different characteristics of large, small, and medium when comparing healthy subjects, depressed patients, and schizophrenic patients. In schizophrenia, it has been reported that a re-elevation change of hemoglobin is observed after completion of the task.
  • the present applicant determines a reference waveform for each disease group and uses the correlation between the waveform of each subject and the reference waveform of each disease group as a reference.
  • a technique for determining a disease is proposed (for example, Patent Document 1).
  • a method for calculating and displaying a disease determination score by calculating the Mahalanobis distance between the measured feature value of the hemoglobin change waveform force and the disease-specific dictionary data is proposed (Patent Document 2).
  • the dictionary data for each disease is classified and categorized based on the disease name added by the user.
  • Non-Patent Document 1 “Dynamics of frontal lobe regional cerebral blood volume in neuropsychiatric disorders ⁇ Examination using Graph '' Masato Fukuda, JSPS Grant-in-Aid for Scientific Research 2001-2002
  • Non-Patent Document 2 "The Mind Seen by Light” Masato Fukuda et al., Mind and Society No. 34 ⁇ 1 separate volume, Japan Mental Health
  • Patent Document 1 Japanese Patent Laid-Open No. 2003-275191
  • Patent Document 2 International Publication WO2005Z025421
  • the present invention provides a biological optical measurement device that improves separation of healthy groups and non-healthy groups, enables simple category generation in disease classification, and can perform effective disease classification.
  • the purpose is to provide.
  • the present invention provides a determination unit that determines a disease by a classification model in an analysis unit that performs waveform analysis of a biological light measurement device, and performs hierarchical classification in the determination unit.
  • a determination unit for determining a disease using a classification model is provided, and a variable obtained by synthesizing a plurality of types of feature amounts is used as a classification model used by the determination unit.
  • the biological light measurement device of the present invention irradiates a subject with light having a wavelength belonging to the visible to infrared region, detects light that has passed through the subject, and measures a hemoglobin change waveform.
  • a feature amount calculation unit that extracts and analyzes a plurality of types of feature amounts from the measured waveform, and a classification model that is set in advance using the plurality of types of feature amounts extracted by the feature amount calculation unit. 1. It comprises a determination unit that performs disease determination and a display unit that displays a determination result of the determination unit, and the determination unit includes a plurality of classification models having a hierarchical structure as the classification model. To do.
  • the determination unit includes a plurality of types as the classification model. It is characterized by using a variable that combines feature quantities.
  • the classification model is, for example, a variable obtained by combining a plurality of types of feature amounts, for example, a linear combination of a plurality of types of feature amounts, and a plurality of subject groups for which disease determination is confirmed. Each is determined to maximize the probability of being classified into the class corresponding to the disease.
  • the biological optical measurement device of the present invention can be used to construct a classification model, for example, a slope value immediately after the start of a task of a hemoglobin waveform, an integral value during task execution, and a re-rise degree after the task ends.
  • the center of gravity value of the entire waveform is used as the feature amount.
  • the feature amount calculation unit extracts a feature amount from a hemoglobin waveform obtained in each of the multichannels of the biological light measurement unit.
  • the present invention provides a disease diagnosis support apparatus in which components other than the biological light measurement unit are separated from the force of the biological light measurement unit.
  • This disease diagnosis support device is the same as the biological light measurement device of the present invention except that the biological light measurement unit is independent.
  • the effect of separating a healthy person group from a non-healthy person group can be enhanced by performing disease classification hierarchically.
  • the classification of disease patient groups is adopted, it is possible to classify diseases effectively by creating a simple category by incorporating hierarchical properties.
  • FIG. 1 is a block diagram showing an outline of the biological light measurement device 100 of the present invention.
  • the biological light measurement device 100 extracts features from the biological light measurement unit 10 and the hemoglobin change waveform measured by the biological light measurement unit 10 and performs various analyzes based on the input of the operator.
  • the feature amount calculation unit 20, the input unit 30 for inputting information necessary for calculation in the feature amount calculation unit 20, and the plurality of types of feature amounts extracted by the feature amount calculation unit 20 A patient is classified into five types, and a decision unit 40 that supports disease diagnosis and analysis results of biological light measurement data obtained from a large number of subjects are stored as disease dictionary data together with definitive diagnosis results and
  • the storage unit 50 stores the waveform data measured by the optical measurement unit 10 and the classification model used by the determination unit 40, and the determination results of the determination unit 40 are registered as a dictionary.
  • the biological light measurement unit 10 irradiates a human head with light, receives light reflected and scattered in the vicinity of the head surface at a plurality of detection positions, and changes signals in the blood (here, hemoglobin).
  • This is a multi-channel device that measures the amount of hemoglobin change for each channel when a subject is exposed to a fluency task with language recall.
  • the specific configuration mainly includes a light source unit 102, a light receiver 108, a lock-in amplifier 109, an A / D converter 110, a measurement control computer 111, and the like.
  • the letters at the end of these codes mean that there are multiple elements.
  • the light source unit 102 and the subject 106 and the light receiver 108 and the subject 106 are connected by an irradiation optical fiber 105 and a light receiving optical fiber 107, respectively.
  • the light source unit 102 includes two light source units 102a and 102b having a first wavelength (for example, 690 nm or 780 nm) and light source units 102c and 102d having a second wavelength (for example, 830 nm). Connected, modulated differently depending on the measurement position, and irradiated to the head of the subject 106 via the couplers 104a and 104b and the irradiation optical fibers 105a and 105b. The light reflected / scattered near the head is collected by receiving optical fibers 107a to 107fC arranged close to the irradiation optical fiber, and photoelectrically converted by the optical receivers 108a to 108fC, respectively.
  • a first wavelength for example, 690 nm or 780 nm
  • second wavelength for example, 830 nm
  • the distal ends of the irradiation optical fiber 105 and the light receiving optical fiber 107 are arranged so that the light receiving positions are arranged at the same distance (for example, 30 mm) from the light irradiation position force.
  • a photoelectric conversion element represented by a photomultiplier tube or a photodiode is used.
  • Electric signals representing the intensity of light passing through the living body photoelectrically converted by the light receiver 108 are respectively input to the lock-in amplifier 109.
  • the intensity modulation frequency from the oscillator 101 is input to the lock-in amplifier 109 as a reference frequency.
  • the light intensity signals from the light sources 102a and 102b and 102c and 102d are separated by the reference frequency, respectively. Is output.
  • the separated transmitted light intensity signal of each wavelength which is the output of the lock-in amplifier 109, is analog-digital converted by the analog-digital converter 110, and then sent to the measurement control computer 111.
  • the measurement control computer 111 calculates the detection signal power at each detection point, the relative change in oxygen concentration to deoxygenated hemoglobin concentration, deoxygenated hemoglobin concentration, and total hemoglobin concentration. Store.
  • Oxygenated hemoglobin concentration One or a plurality of hemoglobin change signals, which are relative changes in the deoxygenated hemoglobin concentration and the total hemoglobin concentration, are used depending on the disease to be determined.
  • the measurement control computer 112 controls the operation of the biological light measurement unit 20. Note that FIG. 2 shows a configuration of a biological light measurement unit that separates a plurality of lights by a modulation method. However, the present invention is not limited to this. It is also possible to use a time-sharing method for discriminating between the two.
  • the elements other than the biological light measurement unit 10, that is, the feature amount calculation unit 20, the determination unit 40, and the storage unit 50 are all in the calculator 112, and the input unit 30 and the display unit 60 are It is provided in computer 112.
  • the computer 111 and the computer 112 may be a single computer. Further, it may be placed at a completely distant place and connected via a communication means such as the Internet. That is, the computer 112 can also be a disease diagnosis support device that is independent of the biological light measurement unit.
  • the feature amount calculation unit 20 analyzes the feature amount based on the waveform data of the measured changes in local oxygenated hemoglobin, deoxygenated hemoglobin, and total hemoglobin. The function of the feature quantity calculation unit 20 will be described later. Waveform data and features are passed to the storage unit 50
  • the storage unit 50 temporarily stores the measurement information of the subject and enables subsequent processing.
  • the measurement information is stored as dictionary data.
  • the dictionary data is used not only when optimizing the classification model (automatic parameter adjustment) used by the determination unit 40 as will be described later, but also when diagnosing with this device.
  • the determination unit 40 uses the feature quantities and classification models stored in the storage unit 50 to determine the subject's disease, specifically, whether a person is healthy or unhealthy for mental illness, Judgment is made regarding which disease the determined person belongs to. Details will be described later.
  • the input unit 30 displays a GUI for the user to input data and commands for control and calculation performed by the computer 112, and enables communication between the user and the computer 112 using the GUI.
  • the display unit 60 stores the feature amount of the subject extracted by the feature amount calculation unit 20 in the storage unit 50. Database information, the result of classification by the determination unit 40 , and the like are displayed.
  • the hemoglobin change signal to be processed by the feature calculation unit 20 is, for example, as shown in FIG. 3, a change in signal intensity in a predetermined time consisting of a waiting time before starting a task and a pause time during and after the task. This is obtained as a waveform 300 indicating (mMmm).
  • the two vertical lines shown in the figure represent the start time 301 and the end time 302 of the task, respectively.
  • tasks are repeated multiple times with a set of load and pause.
  • the hemoglobin waveforms obtained from multiple measurements are averaged and subjected to preprocessing such as smoothing and baseline processing as necessary. Of course, there are cases where the amount of hemoglobin change is determined in a single trial without repeating multiple times.
  • FIG. 3 shows one hemoglobin change waveform, which is obtained for each channel of the biological light measurement unit 10.
  • Non-Patent Documents 1 and 2 show the waveform feature patterns for each of the load diseases for subjects with a language fluency task involving language recall. As shown in the figure, in healthy subjects, the hemoglobin change is large and monotonously decreases after the task ends. In schizophrenia, the hemoglobin change is moderate and the waveform re-rises after the task ends. A small feature is that bipolar disorder has large hemoglobin changes and peaks in the second half of the task.
  • the feature amount calculation unit 20 digitizes these features from the measured hemoglobin waveform 300. Specifically, the slope value 311, the integral value 313, the re-elevation degree 315, and the center of gravity 317 are calculated as feature quantities. Slope 311 is the slope of the hemoglobin waveform calculated from the task start time to 5 seconds. The slope 311 represents the speed of response to the task. The integral value 313 is obtained by integrating the hemoglobin waveform in the section during the task trial. The integrated value 313 is considered to reflect the magnitude of the reaction. The re-elevation degree 315 is obtained by connecting the hemoglobin value at the end of the task and the hemoglobin value at the end of the measurement with a straight line, and calculating the area above the straight line.
  • the rise of 315 seems to reflect a mental tendency not to follow the task order.
  • the centroid value 317 represents the relative time at which the centroid of the waveform is located.
  • the measurement start is zero and the measurement end is one.
  • the center of gravity value 317 is considered to represent the speed of sustained response. It is done.
  • the biological light measuring unit 10 can obtain a hemoglobin waveform and a feature quantity of a plurality of channels in one measurement. Depending on the type of feature quantity, the average waveform value of the measurement region or the maximum value of all channels is used. In the present embodiment, the maximum value of all channels is used for the degree of re-elevation, and the average waveform value in the measurement region is used otherwise.
  • the feature quantity calculation unit 20 further performs a calculation according to the classification model of the determination unit 40 using these feature quantities.
  • the calculation result is used by the determination unit 40 to determine which disease the subject belongs to by applying the classification model.
  • the measured waveforms are classified into five types by hierarchical classification. Responses to subjects of healthy subjects and patients with diseases are very complex, and it is difficult to classify them in one step even by combining the four types of features described above. It becomes possible to classify into groups.
  • Figure 5 shows the hierarchical classification adopted in this embodiment.
  • the first layer 501 classifies the Typel group and the non-Typel group
  • the second layer 502 classifies the non-Typel group into three groups Type2 / Type3, Type4, and Type5.
  • Type2 / Type3 group is classified into Type2 group and Type3 group.
  • the Typel group consists mainly of healthy individuals
  • the Type2 and Type5 groups mainly consist of schizophrenic patients
  • the Type3 group consists of bipolar disorder patients
  • the Type4 group consists mainly of depressed patients.
  • FIGS. 6 to 8 are diagrams showing classification models of the first hierarchy, the second hierarchy, and the third hierarchy and the threshold value thr for determination, respectively.
  • the classification model of the first layer that classifies into the Typel group and the non-Typel group consists of four types of feature values, slope value (D), integral value (I), re-rise (R), and center of gravity (C). It is a variable X_l that is normalized and combined by combining them linearly.
  • Equation 1 indicates normalization.
  • the waveform belongs to the Typel group.
  • the second hierarchy for classifying the group classified as a non-Typel group in the first hierarchy is further divided into two hierarchies of classification using slope values and classification using integral values.
  • the classification model of the third layer is a classification model for classifying Type2 / Type3 group into Type2 group and Type3 group. It is a variable X_23 that is synthesized by combining the above four types of feature values, slope value (D), integral value (1), re-rise (R), and center of gravity (C), and combining them linearly.
  • Equation 2 indicates normalization.
  • the waveform is determined to belong to Type 2 group, and otherwise, it belongs to Type 3 group.
  • classification models in the first to third layers are combinations of features that are considered to represent the features of each disease in a straightforward manner, and the threshold thr and linear combination coefficients C1 to C4, D1 ⁇ D4 is obtained by optimizing the model using dictionary data.
  • optimization of each classification model will be described.
  • the classification model of the first layer is optimized by considering a unit vector c facing a certain direction in a four-dimensional space with a normalized feature amount, and with the vector ⁇ corresponding to one data. Take the product and let it be X. The minimum and maximum values of X are determined for dictionary data, and an appropriate value thr is taken and classification is performed.
  • a vector that maximizes the evaluation function f (u) u * pl + (lu) * p_l Find c and the value thr.
  • the optimized c elements (cl, c2, c3, c4) and the value thr be Cl, C2, C3, C4, and thr_l in equation (1).
  • the optimization of the classification model in the second hierarchy uses, for example, an automatic clustering technique.
  • the threshold value is selected so that the existence probability of each disease group in each type is as biased as possible. That is, the entropy sum E corresponding to the combination j of threshold values (thr_a, thr_b) (j) is
  • pn NC, S, D, BP
  • pn is the ratio of data included in type n to threshold combination j.
  • the determination unit 40 performs disease determination using the classification model described above.
  • Figure 9 shows the disease determination algorithm.
  • the determination unit 40 receives the first layer 901. Determine whether the value X_l in equation (1) is larger than thr_, and classify it as either Typel or Non-Typel. If it is classified as non-Typel, it is further classified as Type2 / Type3, Type4, or Type5 in the second layer 902, 903. If it is classified as Type2 / Type3, it is further classified as either Type 4 or Type 5 in the third layer 904.
  • a subject who has a hemoglobin change with an integration value of 102, a slope of 0.003, a re-elevation degree of 5, and a center of gravity of 0.15 is determined to belong to a healthy person (Typel).
  • Typel contains the most healthy individuals
  • Type2 contains schizophrenia
  • Type3 contains bipolar disorder
  • Type4 contains depression
  • Type5 contains schizophrenia. Will be. However, since these only indicate a high probability, the judgment result is expressed as a high probability.
  • a display method for example, it is possible to display findings such as “high possibility of schizophrenia” and “possibility of depression”, but display them on the scatter chart of the classification model. You can also.
  • FIG. 10 shows an example of a scatter diagram.
  • Figure 10 is a scatter plot of the classification model in the second layer, and the Type area divided by the thr value of the classification model is shown on the graph with the horizontal axis tilted and the vertical axis the integrated value. Each data in the dictionary data is indicated by a symbol.
  • the type to which the subject belongs can be confirmed at a glance, and the distance from other types can also be confirmed.
  • the first layer is classified as belonging to the non-Type 1 group, subjects who have hemoglobin changes with the same integral value 102 and slope 0.003 as in the previous case are distributed in the upper right area on the scatter diagram. It can be recognized that it belongs to Type2 / Type3 group.
  • FIG. 11 shows a procedure from the feature amount extraction described above to the disease determination.
  • An input screen as shown in FIG. 12 is displayed on the input unit 30 to make a disease determination. Accordingly, information necessary for disease determination, examination date, subject number, etc. are entered (step 1101). In this example, the name of the force identifying the subject by number may be used. If there is a confirmed diagnosis result, check the mouth of item 1.
  • the measurement waveform of the corresponding subject is read from the biological light measurement unit 10, and a plurality of types of feature quantities are calculated (steps 1102 and 1103). Next, hierarchical classification is performed based on the calculated feature amount (step 1104). The judgment result is displayed on a scatter diagram as shown in FIG. 10 (step 1105).
  • the test result is automatically stored in the database (storage unit 50).
  • a mental disorder having a complex aspect of waveform characteristics for each disease by performing hierarchical classification using variables that combine feature quantities. Can be automatically discriminated from a healthy person and between disease groups, and the accuracy of discrimination can be increased. In particular, it is possible to grasp the overall trend by comparing and comparing the feature values of the subject (or variables that combine them) and the feature values of the dictionary data (or variables that combine them) on a scatter diagram. However, it becomes possible to determine the disease category.
  • the classification model used by the determination unit 40 is constructed from dictionary data by an optimization method.
  • the accuracy of classification improves as the number of dictionary data increases. Therefore, it is preferable that the living body optical measurement device of the present invention has a function of updating (automatically adjusting) the classification model!
  • the test result is automatically stored in the database.
  • the dictionary data changes by such a dictionary data storage function.
  • the automatic adjustment function is a mechanism that optimizes the classification model parameters again as the dictionary data changes.
  • the optimization method is the same as the optimization method when the classification model is constructed.
  • the evaluation function is set for the set solid c and value thr. Set the maximum vector c and value thr, and use the optimized c element and value thr as the coefficients and thresholds in equation (1) or (2).
  • the automatic clustering technology is used and the threshold value is selected so that the existence probability of each disease group is as biased as possible for each type.
  • a scatter diagram can be used.
  • the thr value calculated by optimization is displayed on a graph plotting each data in the dictionary data.
  • Fig. 13 shows an example of the display screen showing the classification model.
  • a bar graph shows what diseases are present in each disease category classified by the calculated threshold (disease abundance ratio)! .
  • Such a display makes it possible to immediately confirm the classification result (classification accuracy).
  • variable X_l synthesized by linearly combining four types of normalized features, slope value (D), integral value (I), re-rise (R), and centroid (C) Use
  • the correct answer rate was the highest, but 46% of healthy subjects and 31% of non-healthy subjects were judged as typel.
  • C3 0 was also fixed, 21% of healthy subjects and 48% of unhealthy subjects were determined to be typel. From this, it can be seen that the center of gravity (C) and the re-elevation degree (R) are important features for the separation of Typel and non-Typel groups.
  • Fig. 10 is the result of this example. In Fig. 10, it can be seen that the four groups are distributed so as to overlap each other rather than being clearly separated. Still, it is distributed in Type 5, which is a small area of schizophrenia, but with a small slope. The remaining patients with schizophrenia are distributed with the majority of patients with bipolar disorder in the type 2 and type 3 regions where the slope and integral are relatively large. Most patients with depression have a relatively large slope and a small integrated value, and are distributed in the region Type4. Since the number of healthy individuals is large, a considerable number is distributed among non-Typel, especially Type2 / Type3.
  • Example 2 it was determined that Type 2 / Type 3 were 37 cases, and the four types of feature values, slope value (D), integral value (I), and re-elevation degree (R) were further normalized. Judgment was performed using variable X_23, which was synthesized by linearly combining the center of gravity (C).
  • Type 13 is a diagram showing the determination result of the third hierarchy according to the present example.
  • Typel is healthy
  • Type2 is schizophrenia
  • Type3 is Bipolar disorder
  • Type 4 has depression
  • Type 5 has many schizophrenia.
  • Type2 and Type3 showed a tendency to separate schizophrenia and bipolar disorder, respectively.
  • the main feature of the present invention is that the analysis is performed in advance using a plurality of types of feature amounts in the analysis of the waveform measured by the biological light measurement device.
  • a determination function for determining a disease according to a similar model is provided, and various modifications and applications can be made within the scope described in the claims, not limited to the above embodiment.
  • the present invention also includes that the hierarchical classification model automates only the classification of the first hierarchy using a composite variable of a plurality of feature amounts, and allows the user to make subsequent determinations.
  • the display method of the determination result can be appropriately combined with display using characters, display using a dull, and the like.
  • the present invention relates to a disease determination function using an optical measurement result, and can be used for a disease diagnosis support apparatus such as a mental illness.
  • FIG. 1 is a diagram showing a schematic configuration of a biological light measurement device according to the present invention.
  • FIG. 2 is a diagram showing a configuration of a biological light measurement unit.
  • FIG. 3 is a diagram for explaining extraction of feature values of hemoglobin change waveform force.
  • FIG. 4 is a diagram showing waveform characteristics for each disease.
  • FIG. 5 is a diagram schematically showing a hierarchical classification in a determination unit.
  • FIG. 6 is a diagram showing a classification model in the first layer.
  • FIG. 7 is a diagram showing a classification model of the second hierarchy.
  • FIG. 8 is a diagram showing a classification model of the third hierarchy.
  • FIG. 9 is a diagram showing a disease determination algorithm.
  • FIG. 10 is a diagram showing a display example of determination results.
  • FIG. 11 is a diagram showing a disease state determination flow.
  • FIG. 12 is a diagram showing an example of an input screen of the input unit.
  • FIG. 13 is a diagram showing the result of optimizing the classification model.
  • Measurement control computer 112 ⁇ computer (disease diagnosis support device).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

La présente invention permet d'évaluer automatiquement des maladies de sujets à partir des motifs d'ondes caractéristiques des changements dans le niveau d'hémoglobine déterminé en mesurant la lumière biologique, la séparation d'un groupe de sujets sains d'un groupe de sujets malades et la séparation de groupes de maladies individuelles sont améliorées. Dans un appareil (10) pour mesurer la lumière biologique, une section d'analyse, où le motif d'onde est analysé, est muni d'une section d'évaluation (40) par laquelle des maladies sont évaluées en fonction de modèles de classement. Pour mener un classement hiérarchique, plusieurs modèles de classement sont prévus dans la section d'évaluation. En tant que modèles de classement, on emploie les paramètres obtenus en synthétisant les quantités caractéristiques de plusieurs types. Ces modèles de classement sont optimisés par le procédé d'optimisation et automatiquement ajustés en association avec les changements de données.
PCT/JP2006/325814 2006-06-15 2006-12-25 Appareil pour mesurer la lumière biologique WO2007144977A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008521091A JPWO2007144977A1 (ja) 2006-06-15 2006-12-25 生体光計測装置

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-165978 2006-06-15
JP2006165978 2006-06-15

Publications (1)

Publication Number Publication Date
WO2007144977A1 true WO2007144977A1 (fr) 2007-12-21

Family

ID=38831500

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/325814 WO2007144977A1 (fr) 2006-06-15 2006-12-25 Appareil pour mesurer la lumière biologique

Country Status (2)

Country Link
JP (1) JPWO2007144977A1 (fr)
WO (1) WO2007144977A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008142878A1 (fr) * 2007-05-21 2008-11-27 Hitachi Medical Corporation Appareil pour mesurer la lumière biologique
JP2011229413A (ja) * 2010-04-23 2011-11-17 Nagoya Univ 細胞評価装置、インキュベータ、プログラム、および、培養方法
WO2012165602A1 (fr) * 2011-05-31 2012-12-06 国立大学法人名古屋工業大学 Equipement de détermination de dysfonctionnement cognitif, système de détermination de dysfonctionnement cognitif et programme
CN113876320A (zh) * 2021-09-29 2022-01-04 天津用恒医疗科技有限公司 血红蛋白浓度确定方法、装置、电子设备和存储介质

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003275191A (ja) * 2002-03-26 2003-09-30 Hitachi Medical Corp 生体光計測装置
WO2005025421A1 (fr) * 2003-09-11 2005-03-24 Hitachi Medical Corporation Dispositif de mesure de lumiere provenant de l'organisme
WO2005096951A1 (fr) * 2004-04-09 2005-10-20 Hitachi Medical Corporation Appareil de mesure biophotonique
WO2006132313A1 (fr) * 2005-06-09 2006-12-14 Hitachi Medical Corporation Système d'aide à l’évaluation d'une pathologie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2667867B2 (ja) * 1988-03-30 1997-10-27 東亜医用電子株式会社 粒子解析装置
JP2002107366A (ja) * 2000-10-02 2002-04-10 Hitachi Ltd 診断支援システム

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003275191A (ja) * 2002-03-26 2003-09-30 Hitachi Medical Corp 生体光計測装置
WO2005025421A1 (fr) * 2003-09-11 2005-03-24 Hitachi Medical Corporation Dispositif de mesure de lumiere provenant de l'organisme
WO2005096951A1 (fr) * 2004-04-09 2005-10-20 Hitachi Medical Corporation Appareil de mesure biophotonique
WO2006132313A1 (fr) * 2005-06-09 2006-12-14 Hitachi Medical Corporation Système d'aide à l’évaluation d'une pathologie

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008142878A1 (fr) * 2007-05-21 2008-11-27 Hitachi Medical Corporation Appareil pour mesurer la lumière biologique
JPWO2008142878A1 (ja) * 2007-05-21 2010-08-05 株式会社日立メディコ 生体光計測装置
JP2011229413A (ja) * 2010-04-23 2011-11-17 Nagoya Univ 細胞評価装置、インキュベータ、プログラム、および、培養方法
WO2012165602A1 (fr) * 2011-05-31 2012-12-06 国立大学法人名古屋工業大学 Equipement de détermination de dysfonctionnement cognitif, système de détermination de dysfonctionnement cognitif et programme
JPWO2012165602A1 (ja) * 2011-05-31 2015-02-23 国立大学法人 名古屋工業大学 認知機能障害判別装置、認知機能障害判別システム、およびプログラム
US9131889B2 (en) 2011-05-31 2015-09-15 Nagoya Institute Of Technology Cognitive impairment determination apparatus, cognitive impairment determination system and program
CN113876320A (zh) * 2021-09-29 2022-01-04 天津用恒医疗科技有限公司 血红蛋白浓度确定方法、装置、电子设备和存储介质

Also Published As

Publication number Publication date
JPWO2007144977A1 (ja) 2009-10-29

Similar Documents

Publication Publication Date Title
Liang et al. A new, short-recorded photoplethysmogram dataset for blood pressure monitoring in China
JP3543453B2 (ja) 光生体計測法を用いた生体入力装置
JP4555230B2 (ja) 生体光計測装置
US7349727B2 (en) Living body light measuring device
Xu et al. Prediction in autism by deep learning short-time spontaneous hemodynamic fluctuations
JP4518281B2 (ja) 疾患判定支援システム
JP3916985B2 (ja) 生体光計測装置
Hassan et al. Early detection of cardiovascular autonomic neuropathy: A multi-class classification model based on feature selection and deep learning feature fusion
JP6694289B2 (ja) 薬効評価補助システム、及び薬効評価補助情報提示方法
KR102099214B1 (ko) 생체정보 및 영상정보 연계를 통한 인공지능 질환 진단 시스템
JP7217289B2 (ja) 医療介入制御システム
CN109069081A (zh) 用于预测、筛查和监测脑病/谵妄的设备、系统和方法
Zou et al. Constructing multi-scale entropy based on the empirical mode decomposition (EMD) and its application in recognizing driving fatigue
Sappia et al. Signal quality index: an algorithm for quantitative assessment of functional near infrared spectroscopy signal quality
CN109859843A (zh) 智能健康一体机
Zhao et al. Applying machine learning to identify autism with restricted kinematic features
Wang et al. Depression analysis and recognition based on functional near-infrared spectroscopy
WO2007144977A1 (fr) Appareil pour mesurer la lumière biologique
CN116013514A (zh) 一种基于多参数融合的一体化糖尿病足预测系统
Mohebbian et al. Semi-supervised active transfer learning for fetal ECG arrhythmia detection
Gopalakrishnan et al. Itl-cnn: Integrated transfer learning-based convolution neural network for ultrasound pcos image classification
KR100955716B1 (ko) 생체데이터의 문자열 생성 방법 및 장치와, 이를 이용한 생체 파형 검출 방법 및 장치와 맥파 분류 방법 및 장치
Shao et al. EEG-Based Mental Workload Classification Method Based on Hybrid Deep Learning Model Under IoT
JP5043107B2 (ja) 生体光計測装置
Zhang et al. Heart failure classification using deep learning to extract spatiotemporal features from ECG

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06835184

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008521091

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06835184

Country of ref document: EP

Kind code of ref document: A1